Intended for healthcare professionals

CCBY Open access

Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial

BMJ 2020; 369 doi: (Published 14 May 2020) Cite this as: BMJ 2020;369:m1849

Read our latest coverage of the coronavirus pandemic

Linked Editorial

Lack of efficacy of hydroxychloroquine in covid-19